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Introduction
The Centers for Disease Control (CDC, 2014) identifies depression as a serious medical
illness that can negatively impact a person across all domains of life. Elderly adults, aged 65 and
older, are at increased risk for depression because approximately 80% have at least one chronic
health condition–depression is a common co-morbid mental disorder among people with
ongoing, persistent illnesses (CDC, 2014). Older adults homebound with chronic health
conditions use home healthcare (HH) services to help them and their caregivers manage their
illnesses at home and prevent hospitalizations. Although depression in this population is
associated with increased rates of re-hospitalization, falls, and suicides, it is frequently under
diagnosed and under treated (Sheeran, Byers, & Bruce, 2010; Byers et al., 2008; Raue et al.,
2006; CDC, 2014). While clinicians who provide care in the home are well positioned to
identify depressive symptoms in their patients they must have agency and federal-level
stakeholder support to reasonably meet the depression care needs of their patients.
This capstone report presents three manuscripts that explore the provision of depression
care in the HH population. The first report is a literature review of 30 articles investigating
depression screening and depression care in HH patients. Three main themes emerged from the
research: the scope of the problem, depression screening tools, and depression care. Though
many barriers hinder the recognition and treatment of depression in this population, training HH
professionals and working with specialized mental health providers can improve depression
screening and care.
The results of the literature review guided the development and implementation of a
depressive disorder protocol in a HH agency designed to improve recognition of depression in
HH patients and then facilitate connection to care. The second manuscript describes a process
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evaluation of HH clinician fidelity of the protocol and other important process outcomes
associated with implementation. This report concludes by identifying ways in which the Doctor
of Nursing Practice prepared nurse can promote positive practice change in this area.
The final document is a policy position statement that examines the problem of under
identified and under treated depression in HH and then identifies evidence-based interventions
designed to improve depression care in this population. This report culminates with
recommendations for policy change that will encourage and support HH agencies and clinicians
who chose to provide holistic chronic care management by adopting innovative depression care
models.
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Depression Screening and Care in Home Health: A Review of the Literature
Sarah Royse Schirmer, M. Ed., BSN, LPCC, RN
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Depression Screening and Care in Home Health: A Review of the Literature
Each day approximately 1.5 million Americans receive home healthcare (HH) from
greater than 33,000 providers (National Association for Home Care and Hospice, 2010). HH
agencies provide health and social services to chronically ill, homebound older adults who need
intermittent skilled nursing care and/or physical, occupational, or speech-language therapies with
the goal of improving the patient and caregiver’s ability to manage illness at home (U.S.
Department of Health and Human Services, Centers for Medicare and Medicaid Services, 2014).
Most HH patients are over the age of 65 and the majority of them carry a chronic health
diagnosis (Caffrey, Sengupta, Moss, Harris-Kojetin, & Valverde, 2011). In a report released by
the Centers for Disease Control (CDC) in 2011, diabetes (10.1%), heart disease (8.8%),
congestive heart failure (4.3%), malignant neoplasm (3.9%), chronic obstructive pulmonary
disease (3.4%), hypertension (3.4%), and stroke (3.3%) were the most common HH admission
diagnoses. Furthermore, these patients commonly suffered from significant functional
impairment (84%), falls, and lack of caregiver involvement (Caffrey et al., 2011).
These ongoing physical and functional stressors place HH patients at risk for depression,
a mental health disorder characterized by anhedonia (inability to experience pleasure), lack of
energy, and feelings of sadness, hopelessness, and helplessness (Pickett, Raue, & Bruce, 2012;
Shao, Peng, Bruce, & Bao, 2011; American Psychiatric Association, 2013). Significant rates of
comorbid depression have been identified in patients with conditions such as diabetes, heart
failure, and fall risk (Acee, 2014; Mantysekla et al., 2011; Thomas et al., 2008; Byers et al.,
2008). Furthermore, depression increases HH patients’ risk for re-hospitalization, poorer quality
of life, and suicidal ideation (Sheeran, Byers, & Bruce, 2010; Raue, Meyers, Rowe, Heo, &
Bruce, 2006; Diefenbach, Tolin, & Gilliam, 2011).
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In 2010, Qui et al. summarized the risk factors attributable to older adults becoming and
remaining homebound, reporting that patients in need of HH “suffer from physical and
psychiatric illnesses at a much higher rate than non-homebound adults” (p. 2423). Additionally,
depression is reported to be the second most prevalent psychiatric illness among HH patients
(Qui et al., 2010). The following review will examine trends in screening for depression in HH,
then analyze evidence regarding the use of standardized screening tools, clinician training, and
agency protocols to facilitate the identification and treatment of depression in HH patients.
Methods
Literature Review
A review of the literature was conducted using the following electronic databases from
the University of Kentucky Medical Center Library: CINAHL, MEDLINE, PubMed, TRIP, and
PsycINFO. Google and Google Scholar were also used to search for evidence regarding
depression screening in the HH population. The following search terms were used to find
relevant literature: home care, home healthcare, aging/older adults, elderly, screen, detect,
identify, recognize, consequences, chronic illness, diabetes, congestive heart failure, cancer,
comorbidity, mental illness, mood disorder, depression, major depressive disorder, exacerbation,
importance, health outcomes, improve, enhance, develop, elevate, advance, risk (factors),
contributing (factors), rates, statistics, Medicare, and Centers for Medicare and Medicaid (CMS).
Ancestry searching was also used to find relevant literature. Unpublished studies were not
examined. Articles were reviewed considering inclusion and exclusion criteria.
Inclusion/Exclusion Criteria
The analyzed evidence included systematic and integrative literature reviews, randomized
and nonrandomized experimental studies, and non-experimental studies. Articles that focused on
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prevalence, barriers to screening, improving screening, depression care management, and
depression treatment outcomes in HH were included. Articles published before 2000 and
research studies conducted in other countries were excluded from this review to ensure relevance
to the current HH system in the United States. Research involving the pediatric population was
also excluded, as the elderly are the focus of this review. Literature describing screening for
depression involving patients with severe dementia was not included because standard
depression screening tools were not normed for cognitively impaired patients and, therefore,
were not reliable tools for use with this population (Sheeran, Reilly, Weinberger, Bruce, &
Pomerantz, 2010). Only in the past fifteen years has depression in HH been of focus in the
literature. As a result, articles from as early as 2002 were included.
The initial search yielded 35 articles, which were narrowed to 30 after removal of five not
specific to the HH population. Of the 30 articles, four were randomized controlled trials, five
were nonrandomized controlled trials, seven were observational clinical studies, three were
policy briefs, five were clinical intervention descriptions, five were literature reviews, and one
was a qualitative study.
Results
The search produced articles with varying perspectives on depression screening in HH.
The following themes were discovered in analysis of the resulting literature: scope of the
problem, depression screening tools, and depression care models. These themes will be
reviewed as they relate to trends in depression screening. Finally, a discussion will incorporate
literature found regarding the importance of engaging stakeholders in depression screening and
treatment programs in HH.

7	
  	
  

Scope of the Problem
Rates of depression. Using the Structured Clinical Interview for DSM-IV-Depression,
Bruce et al. (2002) interviewed 539 HH patients and determined that 13.5 % met DSM-IV
criteria for major depression and 10.8 for minor depression. Nine years later, Shao, Peng, Bruce,
and Bao (2011) analyzed data from the 2007 National Home and Hospice Care Survey and found
that according to physicians and home health care agencies, 6.4% of the home care population
met criteria for depression. Gellis (2010) reported a 5.7% prevalence rate of major depression
symptoms in his sample and a 16.4% prevalence rate of sub threshold depressive disorder. This
discrepancy (Shao et al., 2011) has raised concerns that depression is under-recognized and
under-treated in patients receiving HH (Brown, Kaiser, & Gellis, 2007).
Untreated depression. Rates of clinically significant depression in HH patients have
been described to be as low as 8.5% and as high as 25% (Ell et al., 2007; Bruce et al., 2002).
Bruce et al. (2002) stated that just as there are concerns that depression often goes undetected in
this population, there is evidence to suggest that it is also substantially undertreated. Of 73 HH
patients who met the criteria for major depression, only 16 (22%) were being treated with
antidepressants and none were involved with counseling or psychotherapy (Bruce et al., 2002).
Furthermore, five (31%) of the 16 patients taking antidepressants were not taking therapeutic
doses and two reported not taking the medication as directed (Bruce et al., 2002). Adequate
depression screening can be an important first step in connecting depressed HH patients to
effective care measures.
HH patients who are depressed, not effectively treated, and continue to meet criteria for
depressive disorders have increased short-term risk of hospitalization (Sheeran, Byers, & Bruce,
2010) and high rates of suicidal ideation (11.7%; Raue et al., 2006) soon after starting home care
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services. Anecdotally, symptoms of depression can also hinder and decrease patient engagement
in treatment with physical and occupational therapies intended to improve functional status
(Acee, 2014). These examples highlight the importance of establishing adequate depressionscreening protocols that will quickly link HH patients to depression care interventions soon after
admission to HH.
Barriers to effective depression screening and care. Many barriers prohibit effective
depression screening in HH. Patient factors such as stigmatization and poor acceptance of
mental illness, especially in older adults, can result in underreporting of depressive symptoms
(Brown, Kaiser, & Gellis, 2007; Valente, 2005). Racial disparities in the identification and
effective treatment of depression have also been noted–older African-Americans are less likely
to be screened for depression compared to Caucasians (Pickett, Raue, & Bruce, 2012).
Clinician factors can also contribute to poor depression screening and care. Studies
indicate that nurses and other HH clinicians report receiving inadequate training on how to
screen for depression (Brown, Kaiser, & Gellis, 2007; Brown et al., 2010; Bruce et al., 2007;
Liebel & Powers, 2013; Valente, 2005). In a qualitative study of nurses’ perceptions of
depression care management researchers found that subjects were more comfortable managing
physical illness and less confident in their ability to provide accurate depression psychoeducation
and care (Liebel & Powers, 2013). Also, treating comorbid chronic illness can be timeconsuming. HH clinicians may already feel overextended and perceive depression screening as
just another task they must complete, resulting in ineffective use of the tools (Valente, 2005).
The misperception that depression is a normal part of aging and the masking of depressive
symptoms by physical/medical illnesses can also prevent effective depression screening and
connection to care (Valente, 2005). Interestingly, clinicians appear to have less confidence in
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their ability to identify and manage depression compared to other chronic illnesses commonly
found in HH patients (Brown et al., 2010, Liebel & Powers, 2013), especially if they are not
aware of how to connect their patients with appropriate depression care resources (Liebel &
Powers, 2013).
Medicare policies regulating HH practice and reimbursement also appear to present
unfortunate limitations. Bao, Eggman, Richardson, and Bruce (2014) reported on a qualitative
study of interviews with nurses and administrators from five HH agencies in which their
perspectives on the feasibility of providing effective and evidence-based depression care were
analyzed. Results indicated that the way HH agencies were paid did not align with providing
quality depression screening and care. The prospective payment system (PPS) pays HH agencies
a fixed, lump sum based on patients’ diagnosis group. Nurses are held to productivity
requirements, usually requiring them to see six to eight patients daily. In the study screening and
treating depression required a great deal of time for some patients. However, the payment
system and productivity requirements remained the same whether the nurse just completes tasks
or if he or she spends adequate time carefully assessing and providing quality care. While some
nurses reported wanting to spend more time with complex, depressed patients they reported
feeling pressured by productivity requirements to quickly rather than thoroughly complete
depression care tasks (Bao, Eggman, Richardson, & Bruce, 2014).
Clinicians are required to complete the Outcomes Assessment and Information Set
(OASIS-C), which is a series of questions used to report functional and clinical data on each
patient and determine appropriate service utilization. This information is also used to determine
how much the HH agency will be paid for the patient’s care each 60-day episode. Responses on
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this form are completed in full at start of care (SOC) and resumption of care (ROC), while
reduced versions are completed at recertification and discharge.
Until the past decade, there has been a lack of importance placed on depression screening
and intervention in HH at the policy and regulatory levels. Historically, CMS and the Medicare
Home Health Benefit have neither regulated, mandated, nor offered any financial incentives for
implementing evidence-based depression screening and care with HH patients (Cabin, 2010).
Although there have been important changes made to the required OASIS assessments and
required documentation, clinicians still report feeling unsupported by Medicare policy (Bao et
al., 2014). As Bao et al. (2014) report, “Medicare’s homebound and skilled need eligibility
requirements, inclusion of depression assessment only in the start of care (SOC) OASIS but not
at other time points, and lack of minimum standards for vendor developed home health
electronic health records (EHR) to support depression care are at odds with evidence-based
depression care and the chronic nature of depression” (p. 908).
Depression Screening Tools
Depression screening in home healthcare. Over the past four years there have been
significant changes to the way HH clinicians are prompted to screen for depression on the
OASIS. Before 2010, clinicians admitting patients to HH used question M0590 on the OASIS,
which was not a standardized tool and only measured one of the two “gateway” symptoms of
depression (Sheeran et al., 2010). Updated in 2010, the OASIS-C now includes item M1730,
which asks clinicians if they have screened their patient for depression using the Patient Health
Questionnaire-2 (PHQ-2) or another tool. This approach prompts the admitting clinician to
screen for depression, provides the PHQ-2 for a quick two-question screen, and allows for other
tools to be used if appropriate. Including an easy to use measure increases the likelihood that

11	
  
	
  

overwhelmed HH clinicians will take the time to screen their patients for depression (Cabin,
2010; Sheeran et al., 2010). Additionally, the PHQ-2 is now being used more frequently in
primary care clinics. This enables HH clinicians to communicate about patients’ depressive
symptoms with primary care providers, increasing their ability to work together in the
assessment and treatment of their elderly, homebound patients (Sheeran et al., 2010).
Including the PHQ-2 on the OASIS-C improves depression screening of HH patients by
providing clinicians with a valid tool (Chunyu et al., 2007) that assesses both of the main
symptoms of major depression: depressed mood and anhedonia (Sheeran et al., 2010). Chunyu
et al. (2007) evaluated the PHQ-2’s criterion validity against the diagnostic criteria for
depression and construct validity with the six scales of the Medical Outcomes Study 12-item
Short Form Questionnaire. At a score of two or greater, with a sensitivity of 100% and a
specificity of 77% for major depressive disorder in older adults (Chunyu et al., 2007), this
screening tool can help HH clinicians determine who may need further screening and
intervention (Sheeran, et al., 2010).
While the PHQ-2 has been determined to be a valid and reliable screening tool in older
adults, with a sensitivity of 77%, Chunyu (2007) recommended that a more in-depth tool be
administered if the patient screens positive for depression. The Patient Health Questionnaire-9
(PHQ-9) is one such tool used to follow up positive screens on the PHQ-2. It has been found
that routine depression screening of HH patients using the PHQ-9 is relatively easy to implement
and can help to identify depression in this population (Ell et al., 2005; Ell et al., 2009). Bruce et
al. (2011) recommend using the PHQ-9 because it is an “efficient, evidence based approach to
quantifying depression severity and changes in severity over time” (p. 483). Like the PHQ-2, the
PHQ-9 is commonly used in primary care, and can therefore be more easily discussed and
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understood between clinicians than the previously used OASIS question (Bruce et al., 2011). As
aforementioned, the HH clinician can opt to use a different depression screener. Madden-Barer
et al. (2013) reported that the Geriatric Depression Scale (GDS), when used as part of a larger
depression care management program, effectively screens for and measures symptom severity
over time. Like the PHQ-9, the GDS is longer than the PHQ-2, with fifteen items (McCormack
et al., 2011). The sensitivity and specificity are comparable to that of the PHQ-9 (Madden-Barer
et al., 2013).
Furthermore, Gellis (2010) describes a depression-screening model HOME: Home Care
and Mental Health for the Elderly. In this model, the eleven-item Center for Epidemiological
Studies-Depression screening tool (CES-D) was completed at SOC. However, in this study it
was found that depression severity was inaccurately assessed using the CES-D. Importantly, this
was thought not attributable to the properties of the standardized screening tool, but to be more a
function of patient underreporting of symptoms, lack of rapport with the clinician, and clinician
attempts to reduce the number of false positive referrals to the depression care program (Gellis,
2010).
In sum, while the PHQ-2 is a simple, 2-question tool that improves the likelihood that
HH clinicians will actually screen their patients for depression, its questionable reliability and
sensitivity warrant a more thorough investigation of depressive symptoms. The PHQ-9, GDS,
and CES-D can be confidently used to follow-up positive screens of the PHQ-2. Furthermore,
none of the previously mentioned tools should be used in isolation to make a diagnosis of
depression by a qualified health professional.
Training to improve depression screening. Evidence suggests that training clinicians
to screen for depression can improve their ability to effectively complete the task (Brown et al.,
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2010; Bruce et al., 2007). Both Gellis (2010) and Bruce et al. (2007) trained agency clinicians
on depression screening and the protocols for depression care referrals. Educators used
strategies such as didactic instruction on depression screening, tool kits on the measurement
tools, video, role-playing, and behavior rehearsal with case examples.
In addition, agencies benefit from working with specialized mental health professionals
when developing and implementing these training protocols (Gellis, 2010; Madden-Baer et al.,
2013). A key component of Gellis’ (2010) training for the HOME program was the use of a
specialized, interdisciplinary team consisting of social workers, a mental health therapist, PhDlevel geriatric depression specialist, and a nurse supervisor. This team worked together to
develop and disseminate the depression-screening training throughout the agency. The study
compared trained clinician scores of depression on the CES-D to researchers’ scores on the
Structured Clinical Interview for Diagnostic and Statistical Manual-IV (SCID-IV). There was a
fair to moderate agreement between researcher and trained-nurse ratings of depression (Gellis,
2010).
Similarly, the Training In the Assessment of Depression (TRIAD) intervention was
developed through collaboration between the involved agencies and researchers to avoid
“increasing nurse burden, devaluing nurses’ clinical skills, or further stigmatizing depression”
(Bruce et al., 2007, p. 1794). Bruce et al.’s (2007) RCT compared trained nurses’ assessment of
depression using OASIS item M0590 (OASIS item used to screen for depression before changes
in 2010) to researchers’ assessment of depression symptoms using the SCID-IV. There was no
significant difference in depression ratings between groups and, furthermore, trained nurses
assessments led to appropriate referrals for depression care treatment (Bruce et al., 2007).
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Madden-Baer et al. (2013) used a team of “specialty-trained psychiatric home care
nurses” (p. 34) to screen for depression in their large HH agency. Psychiatric mental-health
nurses have specific education and/or clinical experience in the field of mental health beyond
what is required of a traditional registered nurse. CMS dictates the requirements needed for a
mental health nurse (MHN) to become Medicare-certified. These requirements vary depending
on the education level and years of clinical experience in psychiatric and mental health nursing,
but must be met in order for the care provided by the mental health nurse to be reimbursable
through Medicare (Thobaben, 2013).
The authors (Madden-Baer et al., 2013) conducted a retrospective chart review from
September 2010 to September 2011 to determine if an evidence-based depression care
management (DCM) protocol can be implemented in a financially, operationally, and clinically
feasible manner at the Visiting Nurse Service of New York. The MHNs used the GDS to screen
for depression and used cognitive-behavioral therapy (CBT) techniques to assist patients with
goal setting and exploring negative thoughts and feelings. The MHNs also provided medication
monitoring and psychoeducation. Additionally, psychiatrists and psychiatric nurse practitioners
provided home-based evaluations and consultations including recommendations for medications
that were communicated to primary care providers. In this case, using specialty mental health
nurses led to accurate screening and improved access to depression care, reducing patients’
symptoms of depression. This highlights the need for including specialized training, education,
and/or experience with depression screening–it is not sufficient to simply include a depression
screener in an admission protocol. Clinicians must be familiar with the tool and the mental
health disorder as it presents in elderly, homebound patients.
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Therefore, Sheeran et al. (2010) provided an in-depth review of the history of depression
screening included on the OASIS and described the rationale for including the PHQ-2 on the
tool. This descriptive review reads as a training guideline educators can use to orient HH
clinicians to depression screening. Sheeran et al. (2010) highlight the need to describe major
depression and screening and treatment barriers in the HH population. Also, the PHQ-2 should
be thoroughly understood by HH clinicians as should methods for discussing depression
treatment with patients and making appropriate referrals for care (Sheeran et al., 2010).
Screening as Part of Larger Depression Care Models
The U.S. Preventative Services Task Force (USPSTF, 2012) provides screening
recommendations for adults; however, these are not specific to geriatrics or HH. The
recommendations state that routine screening for depression is suggested only if there are proper
supports in place to ensure accurate diagnosis, treatment, and follow-up. Evidence suggests that
providing depression care management in the home can alleviate depressive symptoms in
homebound adults (Cabin, 2010; Ell et al., 2007; Madden-Baer et al., 2013). For that reason, the
Community Preventative Services Task Force (2014) recommends depression care at home when
indicated.
Over the past decade innovative depression care programs have been developed to meet
this need. Accurate depression screening must precede depression treatment and, therefore, is
included in all of these programs. Results of the depression screening should guide clinicians as
they determine if patients are appropriate for depression care programming (Bruce et al., 2011a;
Bruce et al., 2011b; Ell et al., 2005; Ell et al., 2007; Gellis, 2010; Gellis, Kenaley, & Have, 2014;
Madden-Baer et al., 2013). These programs vary in terms of the screening tools and treatment
modalities used as well as in the mental health professionals available for consultation and
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collaboration. Depression care models such as I-TEAM (Gellis, Kenaley, & Have, 2014),
HOME (Gellis, 2010), Visiting Nurse Service of New York’s Behavior Health Program
(Madden-Baer et al., 2013), and Homecare to Overcome Problems of Elders with Depression
(HOPE-D; Ell et al., 2005; Ell et al., 2007) were developed with the available resources and
infrastructure already in place within their respective HH agencies and surrounding communities.
The HOPE-D (Ell et al., 2007) intervention was designed to improve quality of
depression care to HH patients by including routine depression screening using the PHQ-9 and
collaborative care elements such as using a depression care manager and psychiatric prescriber,
outcome measurement, and algorithm-based care similar to that used in the IMPACT outpatient
intervention (Untzer, Harbin, & Schoenbaum, 2013). Patients who did not receive the
intervention did receive enhanced care as usual, which was provided by nurses newly trained on
depression screening and care techniques (Ell et al., 2007). While depression scores of patients
who received care in the intervention group were consistently better, the differences did not
reach statistical significance. Researchers believe training the entire nursing staff on depression
management and implementing new techniques in both groups enhanced nursing care regardless
of whether or not the algorithm was used. Of most significance, this study demonstrated that
training staff and implementing depression care is feasible and can improve depressive
symptoms (Ell et al., 2007).
Bruce et al. (2011a) and Bruce et al. (2011b) developed CAREPATH as a result of their
2007 trial (Bruce et al., 2007) evaluating the impact of depression screening training on
depression evaluation and referral skills. Built around the use of the PHQ-2 imbedded in the
OASIS-C, they provide a detailed guide for developing depression care programs in Medicarecertified HH agencies. The authors emphasize that program developers must be cognizant of
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policies and procedures that are unique to each agency and encourage developers to consider
ways in which the HH infrastructure must support the program (Bruce et al., 2011a). For
instance, CAREPATH’s guidelines for case coordination are adaptive depending upon the
resources available to the HH. As the authors pointed out, “Typically these guidelines require
clinicians to contact the patient’s physician, although agencies with psychiatric nurses, clinically
trained social workers, or access to other mental health specialists may designate these clinicians
as the initial point of contact.” (Bruce et al., 2011b, p. 484).
Researches launched a large-scale, randomized trial involving six agencies to determine
if patients who receive the CAREPATH intervention show greater improvements in depression
scores compared to patients who receive usual care as determined by each individual agency
(Bruce et al., 2015). Patients who scored 3 or greater on the PHQ-2 were eligible for
randomization to either group. The CAREPATH intervention provided clinicians with a clinical
protocol and agency support for depression care. CAREPATH encourages agencies to train all
nurses to deliver depression care management if indicated with patient scores 3 or greater on the
PHQ-2. The protocol directs nurses to further assess depression using the PHQ-9 to focus
resources on patients who have the greatest need for depression care. Investigators used the
Hamilton Scale for Depression (HAM-D) to measure the intervention. The results showed that,
while in the full sample the intervention had no effect, patients with severe depression who
participated in CAREPATH had lower depression scores compared to similar patients who
received usual depression care.
Using their agency’s available resources, Gellis, Kenaley, and Have (2014) developed an
innovative telehealth model known as I-TEAM for depression care provided to HH patients–the
only use of telehealth in the literature reviewed. The PHQ-2 was used to screen for depression in
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a moderately large (9,000 patients annually) HH agency. Patients who scored three or greater
were included in this study and were randomly assigned to either care as usual or the treatment
group. The intervention consisted of remote assessment and treatment of chronic illnesses such
as congestive heart failure, alongside treatment of depression using a focused, problem-solving
approach. Pre and post depression scores using the PHQ-9 and the Hamilton Depression Rating
Scale were compared to a group of HH who scored 3 or greater on the PHQ-2 at admission, but
received care as usual (psychoeducation, medication management, etc.). PHQ-9 and Hamilton
Depression Ration Scale scores were 50% lower in the treatment (I-TEAM) group compared to
those who received care as usual.
Overall, the literature reviewed pointed to the importance of adopting screening and
treatment protocols that could make use of and work with existing resources as much as possible
(Bruce et al., 2011b). While some additional policies and procedures may need to be
implemented to promote safety and quality, successful depression care programming is careful to
minimize financial and work burden to the agency and keep all stakeholders’ goals in mind
Discussion
Over the past six years there have been some policy changes within the Centers for
Medicare and Medicaid (CMS) that have improved HH clinician access to standardized
screening tools for depression. However, several barriers to depression screening and care still
exist in this setting. For instance, screening for depression is not mandatory (Cabin, 2010).
Furthermore, while the PHQ-2 is included on the OASIS-C and it is recommended that a positive
screen be followed-up with a more in-depth evaluation, CMS provides no guidance concerning
the most appropriate instruments to use. This may result in difficulty comparing depression
scores and program effectiveness across HH agencies.
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The most striking barriers, however, are at the organizational and financial levels. While
HH clinicians are prompted to screen for depression, there is no indication that scores will have
any impact on Medicare payments (Bao et al., 2014; Cabin, 2010). HH companies, therefore,
have been reluctant to spend time and money on programming that will have little to no apparent
financial benefit.
According to this review of the literature, DCM protocols that include depression
screening have been developed but are sparsely implemented in HH agencies throughout the
country. Presumably this is because of the lack of support from CMS and the home health
benefit in leveraging agency resources to address depression in this population. Future research,
then, should focus on describing the cost-effectiveness of implementing depression care
management protocols in agencies across the country in a variety of settings and communities.
Researchers should focus on combining recommendations for evidence-based depression
screening and practice in the home with ways to make this programming financially feasible.
This way, HH agencies will be more likely to embrace existing protocols. Researchers may want
to focus on highlighting how addressing depressive symptoms early on in the HH admission may
cut down on costly re-hospitalizations, falls, and hip fractures, for example. Overall, this body of
research would be enhanced with the addition of more rigorous examples of depression care
protocols implemented in clinically and cost-effective ways.
Conclusions
Due to the HH population’s high risk for depression, screening and care management
interventions for depression are recommended. Changes to the OASIS-C assessment have
improved clinician access to standardized screening; however, there is little financial benefit, nor
other types of incentives, for HH agencies to promote DCM. Furthermore, there are also patient
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and clinician barriers that make screening for depression among HH patients difficult. Future
research should focus on examining not only the clinical benefit, but also the financial benefit of
implementing such protocols. Depression care management protocols that include cost-saving
ideas may help put this body of research into much needed action all over the country.
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Introduction
Homebound status, decreased functionality, and co-morbid chronic illnesses
increase home healthcare (HH) patients’ risk for depression; the diagnosis of a chronic
disease raises the likelihood of a depressive disorder (Center for Disease Control and
Prevention, CDC, 2012). Egede (2007) reported that the age-and-sex-adjusted odds ratio
of having comorbid depression with any chronic disease is 2.6, meaning that the likelihood
of having depression increases by 160% when an individual has a chronic illness.
Elderly adults receiving HH experience depression at a disproportionately higher rate, with
almost one third of home care patients meeting criteria for major depression (Pickett, Raue,
& Bruce, 2012). Home healthcare patients over 65 years of age more commonly have a
diagnosis of depression compared with their same-age peers in primary care (Bruce et al.,
2002).
Depression correlates with poorer health outcomes and greater healthcare costs (Katon,
2011; Fulop, Strain, & Stettin, 2003). Depressive symptoms demonstrate a strong association
with mortality in cancer and diabetes patients (Park, Katon, & Wolf, 2013) elevated rates of rehospitalization following acute myocardial infarctions (Reese, Freeland, Steinmeyer, Rich,
Rackley, & Carney, 2011), and greater use of medical resources in patients with congestive
heart failure (Fulop, Strain, & Stettin, 2003). Despite the negative impact, depression often
remains undetected and unaddressed in this population (Bruce et al., 2002; Brown, Kaiser, &
Gellis, 2007).
Screening for Depression in the Home Care Population
Understanding the need to screen home health patients for depressive symptoms, in
2010 the Centers for Medicare and Medicaid Services (CMS) included the Patient Health
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Questionnaire-2 (PHQ-2; Appendix A) on the Outcome and Assessment Information SetClinical (OASIS-C), an admission form required for all Medicare patients receiving HH. The
PHQ-2, a standardized depression-screening tool, has proven reliable in detecting major
depression in older adults (Chunyu, Friedman, Conwell, & Fiscella, 2007; Sheeran et al.,
2010). The PHQ-2 consists of two questions (the first two questions of the Patient Health
Questionnaire-9; PHQ-9), which assess the main symptoms of major depression: depressed
mood and anhedonia (i.e., the inability to experience pleasure). Assessors ask patients to
think about their mood over the previous two weeks and then answer the screening questions,
indicating the frequency of the symptoms. PHQ-2 scores can range from 0-6; a cutoff score
of three or greater has a sensitivity of 87% and a specificity of 78% for major depressive
disorder (Sheeran et al., 2010). Therefore, researchers recommend that patients who score three
or greater on the PHQ-2 should subsequently receive a more thorough evaluation (Bruce et
al., 2011, Chunyu et al., 2007; Sheeran et al., 2010), such as the PHQ-9. This screening
tool—readily available from CMS—allows for easy administration with HH patients and can
help identify depression in this population (Ell, Unutzer, Aranda, Sanchez, & Lee, 2005; Ell
et al., 2007).
Need for Training
While these tools are available in HH, many nurses say that they feel unprepared or
inadequately trained to screen for depression (Brown, Kaiser, & Gellis, 2007; Brown, Raue,
Boos, Sheeran, & Bruce, 2010; Bruce et al., 2007; Valente, 2005). Nurses report feeling
uncomfortable asking the screening questions because of fear of what the patient might say and
then not knowing what to do with the answers (Liebel & Powers, 2013). Providing nurses with
depression care management training can resolve this problem (Bruce et al., 2015). Nurses
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trained to screen for depression and to use agency-specific protocols for connecting patients to
depression care show increased confidence in their ability to complete the screening (Brown et
al., 2010). In addition, training improves nurses’ abilities both to identify patients who would
benefit from further evaluation and care, and to complete the referral process (Bruce et al.,
2007). For patients who have moderate-to-severe depression, a nurse-led combination screening
and care management model can significantly decrease depression scores (Bruce et al., 2015).
Although examples of depression care programming exist (Bruce et al., 2015), the resources
required to complete depression screening and care may deter overextended HH clinicians and
financially minded administrators (Bao, Eggman, Richardson, & Bruce, 2014; Valente, 2005).
As a result, agencies must look for ways to reinforce depression screening and to build
depression care into their existing operational structure and budget (Bao et al., 2014).
Home Care Agency Background
In order to meet the depression care needs of its patients, a large HH agency in the
Midwest developed and adopted a mental health program featuring a depressive disorder
protocol. The agency has an average monthly census of approximately 2,386 patients and served
14,021 patients in 2014, approximately 61.5% of who receive Medicare (M. Brents, personal
communication, March 2, 2015). Operating six branches and employing approximately 150
registered nurses and 90 therapists, this organization is the largest HH agency in the region (M.
Brents, personal communication, March 2, 2015).
Prior to administration recognizing that the agency would benefit from formalized mental
health programming, ten mental health nurses (MHN) managed the care of patients with mental
illnesses across the service area. Mental health nurses working in home care “… have special
training and/or experience beyond the standard curriculum required for a registered nurse (U.S
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Department of Health and Human Services, 2011, p. 56). These specially trained nurses provide
evaluation, psychotherapy, and education required of patients presenting with mental health
problems or recent changes in psychiatric care (U.S Department of Health and Human Services,
2011). Before the development and implementation of the depressive disorder protocol the
agency had unclear standards for screening and the referral process for connecting patients to a
MHN. The newly designed depressive disorder protocol outlines specific steps for depression
screening and guidelines for making a referral to a MHN within the agency for further evaluation
and care (Appendix B). The purpose of this paper is to describe a process evaluation intended to
measure clinician adherence to the depressive disorder protocol and other important process
outcomes.
Process Evaluation
Objectives
The principal investigator (PI) conducted a process evaluation to assess HH clinician
adherence (fidelity) to the depressive disorder protocol implemented at a HH agency during the
summer of 2014. Process evaluations yield important information concerning whether or not
program protocols and interventions were implemented as intended (Grembowski, 2001).
Measurement of fidelity, one important process evaluation component, tells us how well
clinicians adhere to intervention procedures according to the program design (Hodges & Videto,
2011).
The evaluation addressed the following questions: What is the level of HH clinician
adherence to the program’s depressive disorder protocol? Was there a difference in clinician
screening and referral practices pre– versus post–program implementation? Agency leaders will
use this information to determine how well the depressive disorder protocol is being followed and
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to uncover significant barriers toward program implementation. Protocol adaptations will be
made accordingly.
The process evaluation also investigated whether patients who have clinically
significant PHQ-2 scores were more likely to be diagnosed with depression. An additional
goal was to determine if a PHQ-2 score of ≥ 3 is associated with changes in
psychopharmacology treatment approaches after program implementation. The researcher
sought to know if agency training could be associated with the frequency of which patients are
prescribed an antidepressant or benzodiazepine while receiving HH. A review of diagnoses
will provide some indication of whether or not depression care programming is associated
with changes in HH coding practices, which might indicate an increased awareness of
depression in the agency and willingness to document it as a primary problem. A review of
pharmacologic interventions will allow program developers to determine if depression care
programming is associated with appropriate psychopharmacological treatment choices for
depressed HH patients.
Methods
Study design
A descriptive, retrospective design was used to examine the research questions. A
convenience sample was selected for participation in the study. The Medical Institutional Review
Board approved all study procedures prior to conducting the study. Procedures for ensuring
participant anonymity and confidentiality were followed throughout the duration of the study.
Sample. The study sample consisted of all HH patients admitted to the agency between
April 1, 2014 through April 30, 2014 and September 1, 2014 through September 30, 2014. All
patient admissions during these time periods were reviewed to identify patients who met
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inclusion criteria. Inclusion criteria were: a HH patient aged 60 or older who had a Medicare
health plan as their primary health insurance. The researcher obtained additional data only from
patients who scored ≥ 3 on the PHQ-2 screener at admission, because these scores trigger further
action according to the protocol (Appendix B). Exclusion criteria were documentation of severe
cognitive impairments and non-English speakers because these factors prevent accurate
administration of the PHQ-2 screener.
Study Procedures
Staff training. During the summer of 2014 all field clinicians who administer the OASISC admission (registered nurses and therapists) completed two, one-hour training sessions consisting
of didactic instruction and case study review on depression screening for HH patients. A total of
250 staff members participated in the training. The training included the following content:
Appropriate administration of the PHQ-2 (Appendix C); identification of patients who need
further evaluation by a MHN, according to the depressive disorder protocol (Appendix B); how
to make an in-house referral for a MHN for further evaluation. In addition to the agency-wide
training, the MHNs received two, three-hour training sessions reviewing the mental health
program. Approximately one hour of this training was spent reviewing and becoming familiar
with the depressive disorder protocol and reviewing appropriate administration of the PHQ-2 and
PHQ-9. Mental health nurses were also made aware of how other field clinicians would be
prompted to refer for a MHN evaluation.
Data extraction. The PI collected data from the EMR at the following time points: April
1, 2014 through April 30, 2014 and September 1, 2014 through September 30, 2014. A total of
1,318 OASIS-C admissions were reviewed. These included 664 patients that were admitted
between April 1, 2014 and April 30, 2014, and 654 that were admitted between September 1,
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2014 And September 30, 2014. The researcher reviewed the EMR to obtain the following
patient/admission information: age, race, sex, primary and secondary diagnoses, and
medications. In addition, specific depression screening data were obtained, including presence of
PHQ-2, PHQ-2 score, presence of MHN referral, reason for absence of a MHN referral in those
with an indication, presence of PHQ-9, PHQ-9 score, and reason for absence of score in those
with an indication. The PI extracted all data. The researcher reviewed the data taken from each
patient admission located on the EMR and then coded (Table 1) and recorded it on the
demographic collection (Appendix E) and study variables extraction forms (Appendix F).
A master list containing patient identifiers and an assigned ID acted as the only link
between the data and the patient record. The researcher de-identified (except for the master list)
and electronically saved the data on a password protected SPSS version 21 file on an encrypted,
password protected thumb drive. All protected health information was accessed electronically
and no printing or recording of protected health information occurred.
Data analysis. Means and standard deviations were used to measure characteristics of the
study sample. Chi-square analysis with Yates' Continuity Correction was used to measure
differences in the frequency of MHN referrals pre-and post training, and independent t-tests were
used to measure differences in PHQ-2 scores pre-and post-intervention. In addition, Fisher's
Exact Test was used to measure differences in the rates of PHQ-9 use pre-and post intervention.
A p value of .05 was used for all analyses. All statistical analyses were conducted using SPSS
version 21.
Results
Among the 1,318 admissions that had a documented PHQ-2 score, no significant
differences appeared between the average PHQ-2 scores pre (M=0.40, SD=1.09) versus post
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(M=0.42, SD=1.03) training. In addition, 30 pre-training patient admissions in April, and 28
post-training admissions in September met criteria for further review (score of ≥ 3 on the PHQ9). Statistical analyses revealed no significant differences in demographics (age, sex, and
ethnicity) between the patients of whom the admissions were reviewed pre vs. post groups
(Table 2). A comparison of the PHQ-2 scores for the pre and post groups who met inclusion
criteria (Table 3) indicated that there were no significant differences between the scores for preintervention (M=4.67, SD=1.028) and post-intervention (M=4.21, SD=0.995; t (58) = 1.70, p =
0.95, two-tailed).
No significant difference was found between the frequencies of clinicians making MHN
referral when indicated pre vs. post intervention, χ2 (1, n=58) = .079, p = .778, (Table 3). The
PHQ-9 was administered at a significantly higher rate in the post-intervention group (p = .038),
but there was not a significantly higher average PHQ-9 score in the post-intervention group (pre:
M = 7.5, SD = 4.9, post: M = 15.75, SD = 4.7), t (1.5) = 1.126, p = .208 (Table 3). There were no
significant differences found between pre– and post–intervention groups with respect to having a
primary or secondary mood diagnosis (p = .905) or being prescribed an antidepressant (p = .80)
or benzodiazepine (p = .72) during the HH episode(s) of care (Table 4).
Clinicians documented a total of six reasons for not adhering to the depressive disorder
protocol (Table 5). Two patients refused a MHN evaluation pre-intervention and one patient
post. Documented reasons for not following up positive screens of the PHQ-2 with the PHQ-9
included, “GAD completed instead. Anxiety primary problem,” and “Geriatric depression scale
used,” and “Not appropriate for patient presentation.” Overall reasons for not adhering to the
depressive disorder protocol were not well documented in either group, with a slight worsening
of percentages post-intervention (Figure 1).
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Discussion
After clinician training on the use of a newly implemented depressive disorder protocol,
clinicians increased use of PHQ-9 to follow up positive screens on the PHQ-2. The average
post-intervention PHQ-9 score (17.75) was not significantly higher due to the small sample size,
however; the pre-intervention average was substantially lower (7.5). This suggests that the
likelihood of clinicians using the PHQ-9 increased when included in a formalized protocol and
reviewed in training sessions. Clinicians may have been more comfortable asking the screening
questions and recording the answers post-intervention. This may be because trained clinicians
knew how to ask the questions and had programming available to help them decide how to make
clinical decisions accordingly.
The idea that HH clinicians tend to be uncomfortable with depression screening, but that
training can increase confidence, has been reported previously in the literature (Ell et al., 2005;
Leibel & Powers, 2013; Brown et al., 2010). Ell et al. (2005) reported in their study of
depression screening in HH that nurses expressed feeling uncomfortable asking highly emotional
questions and tended to avoid or put off discussions of difficult topics that would have come up
during the screening process. In a descriptive study of how HH nurses perceive depression
management researchers found that some nurses believe they are unqualified to provide
depression care alongside other chronic diseases (Leibel & Powers, 2013). Generalist-nurses
relayed feeling self-conscious (afraid of saying the wrong thing) when asking depressionscreening questions (Leibel & Powers, 2013). The authors (Leibel & Powers, 2013) reinforce
that training and formalized agency support for depression screening and care management leads
to increased clinician comfort with depression screening and care (Brown et al., 2010). In a
randomized study of the effects of the Training in the Assessment of Depression (TRIAD)
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program, researchers found that nurses who received training had significantly higher confidence
in their ability to assess depressed mood (Brown et al., 2010).
An alternative interpretation of the PHQ-9 being administered more frequently postimplementation points to the role of the MHN as an important factor. The protocol urged
clinicians to refer patients with elevated PHQ-2 scores (three or greater) to the MHN who would
then further evaluate using the PHQ-9 and follow up with depression care. The specialized
experience and training required of the MHNs may explain the increased rate of PHQ-9
administration. This factor was not controlled for and as a result complicates interpretation of
this data point.
Clinicians referred patients with a PHQ-2 score of three or greater for a MHN evaluation
at the same rate pre- and post-intervention. This result may be interpreted several ways. First,
clinicians documented that a total of three patients refused the MHN evaluation when offered.
Although, clinicians were trained to record a reason for not adhering to the protocol (to assist
with program monitoring and modification) this was not routinely completed pre (13.3%
completion) or post-training (8.3%). Thus, rates of referring to a MHN per the protocol are
probably not accurately described and may actually be higher than the data suggests.
The lack of change in rate of referral may also be explained by patient factors. The
stigma of mental illness continues to be a great barrier preventing many people from seeking
care for treatable mental health conditions (Brown et al., 2007; Valente, 2005). Even if the
MHN referral was offered it is possible that some patients refused because of the negative
associations that go along with admitting depression. In other cases patients have established
rapport and built trust with specific clinicians and so are reluctant to open up and tell their story
again (Valente, 2005).
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Clinician and agency dynamics may also play a role in the low referral rate post program
implementation. Throughout the duration of agency-wide training, currently employed MHNs
resigned, and newly hired MHNs began orientation. The PI conducted training and gathered the
data during a time of transition on the mental health team. It takes time to train new nurses and
prepare them for fieldwork; therefore staff coverage in some regions was light occasionally
during the study. Anecdotally, some field clinicians indicated that it could take up to several
weeks for a patient to be seen by a MHN. It is suspected that in a few cases the patients who
scored greater than three on the PHQ-2 were not seen by a MHN because of staffing problems or
because referring clinicians grew weary of the waiting and simply did not refer. However, the
rationales for lack of referral were often not documented, and it is difficult to determine the
impact of this factor on protocol adherence.
Among patients who scored three or greater on the PHQ-2 there were no significant
differences in psychopharmacological treatment choices pre- versus post-implementation of the
depressive disorder protocol. This could partially be explained by the nature of the intervention.
The depressive disorder protocol used at this agency urged clinicians to screen and then refer
patients to a MHN for further evaluation and treatment. Patients who were receiving care from a
MHN were not clearly identified and this factor was not controlled for in the data analysis;
therefore this outcome is difficult to measure.
There was also no difference in the frequency of being diagnosed with a mood disorder
pre- versus post-implementation. It is probably true that this variable was measured too soon
after implementation of the program and likely a better indicator of program impact on the
agency coding and billing practices as well as Medicare reimbursement rules. Medicare home
health conditions of participation and payment structure tend to emphasize physical health and
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create barriers for administrators and clinicians who strive to make providing quality mental
health care a priority (Bao et al., 2014; Cabin, 2010). Before design and implementation of the
intervention agency leaders worked hard to justify the financial benefits of the mental health
program and disprove fear that focusing clinician resources on depression and other mental
illness would be financially untenable for the agency. While this evaluation was not concerned
with the cost-effectiveness of providing depression care, future research should focus on this area
so that HH leaders are assured that depression care models can be comfortably implemented in
the home care setting while improving the health of their patients.
Limitations
Several limitations of the depressive disorder protocol process evaluation emerged and
warrant mention. First, the descriptive design makes interpretation and generalization of the
process evaluation results difficult. Secondly, the sample size was quite small because of the
limited time frames from which the data was reviewed and the infrequency of patients meeting
inclusion criteria. In charts of patients who did meet criteria for inclusion, the PI found data in
various places within the EMR. Clinicians did not use the same areas of the EMR to document
information regarding the depressive disorder protocol or non-adherence to the guidelines. In
this case accuracy of data retrieval is challenged. Both of these limitations call into question the
ability of the data to explain current practices and, thus, make it difficult to make informed
recommendations.
Before future program monitoring efforts begin it is recommended that clinicians be
notified of exact locations in the EMR where they are to document specific pieces of information
about the depressive disorder protocol. Also, researchers are encouraged to utilize a time series
approach over periods of months in lieu of a descriptive design so that threats to validity are
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decreased and so that evaluation results are more clearly a reflection of the current state of
practice (Linden, Adams, & Roberts, 2003).
The Doctor of Nursing Practice to Promote Positive Change
As the terminal practice degree in the field, the Doctor of Nursing Practice (DNP)
prepares clinical nurse scholars to lead the dissemination of safe, quality, and innovative
healthcare around the globe (Chism, 2010). With a firm understanding of how the evidence-base
should inform and guide practice, the DNP is well positioned to improve how depression is
addressed and treated in the elderly HH population. The DNP curricula cultivate competencies
necessary for leadership and growth in all nursing specialties, including psychiatric/mental health
care. Using the eight Essentials of Doctoral Education for Advanced Nursing Practice developed
by the American Association of Colleges of Nursing, the DNP education prepares nurse leaders
who understand the complexities of healthcare systems and who are also dedicated to continuous
practice improvement at all stakeholder levels. These essentials help to explain how the DNP can
be leveraged to promote positive practice change in this area (Chism, 2010).
DNP graduates are trained to use information technology to track program, financial, and
clinical outcomes in order to evaluate and enhance practice (Essential IV; Chism, 2010). Before
administrators endeavor to conduct future evaluations of the mental health program, steps should
be taken to improve the agency’s ability to use software and reports to monitor mental health
program processes and clinical outcomes. First it is critical that clinicians are documenting
information in the same place within the EMR. This agency uses a software package that
encourages thoroughness of documentation, however; data collection can be time consuming and
difficult if the data are not located in a predetermined location. One solution is to direct
clinicians to create a case communication note with a heading “Mental Health” to communicate
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their impressions, assessments, interventions, and referral suggestions as they pertain to the
patient’s mental health as well as the patient’s response. This could involve a “cut and paste” of
a clinical note or additional documentation of their concerns and recommendations.
Similarly, evaluations could be conducted more smoothly if quick reports could be
generated. It is common within this agency to keep track of patient and clinician statistics with
the simple click of a mouse and conjuring of a report. Patients who receive services from a
MHN should be assigned to a mental health team and important clinical and financial outcomes
should be defined in the treatment plan. This evaluation could have been more in depth if the PI
had been able to generate a report of all the patients who scored three or greater on the PHQ-2.
However, every patient admission (over 1,300) had to be opened and screened for the PHQ-2
score first. As a marker for depression and depressive disorder protocol use, it is recommended
that administrators request that reports of patients who screen positive on the PHQ-2 be available
through their software vendor(s).
Understanding the importance of using data to inform practice, the DNP prepared nurse
uses scientific findings from a variety of sources to evaluate and further develop care delivery
(Essentials I, II, & III; Chism, 2010). It is recommended in this case that this descriptive
evaluation be followed up by a qualitative design investigating clinician perceptions of the
usefulness and function of the mental health program and depressive disorder protocol. It is
important to know from the people who see and care for these patients every day, “Is it
working?” The agency may find common themes emerge that would identify areas for process
and quality improvement.
Even with a fairly large mental health team this process evaluation indicated that some
patients who have clinically significant depression scores were not seen by a MHN. It is not
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reasonable for ten nurses to serve the depression care needs of 310 patients (13% of average
monthly census–estimated population of HH patients who will meet criteria for clinically
significant depression). One solution to problems with coverage and long wait times is to train
all nurses to manage depression. Embracing more of a collaborative care model, the agency
might choose to train all 150 nurses to manage depression like other chronic diseases. Doctorallevel prepared psychiatric/mental health nurses are trained to emphasize the importance of
collaborative care among interdisciplinary teams and can provide specialized education on
depression screening and care to skilled nurses and other HH personnel (Essential VI; Chism,
2010).
DNP clinicians examine healthcare policy at all stakeholder levels and create feasible
solutions to increase access to quality healthcare (Essential V; Chism, 2010). As described, some
existing HH policies do not support the provision of depression care in this population. The
following manuscript considers this and offers suggestions for sensible policy changes at both
federal and local levels.
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Table 1. Coding of Process Indicators/Outcomes
Process Indicator/Outcome

Chart Item Reviewed

Was PHQ-9 administered according
to protocol?
Was a MHN referral made according
to protocol?

PHQ-9 completed

Did patient have primary or
secondary mood disorder diagnosis?
Was patient prescribed an
antidepressant during home health
episode(s) of care?
Was patient prescribed a
benzodiazepine during home health
episode(s) of care?

	
  

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

Coding–
Present/Not
Present
1/0

MHN referred and completed evaluation.
Reviewed orders, case communication
notes, and visit tree.
Home health diagnoses found on patient
profile
Medication list

1/0

Medication list

1/0
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1/0
1/0

Table 2. Differences in sociodemographic characteristics pre- and post-intervention
Overall sample
(N =58)

Age, mean
Female, n (%)

71.5
41 (70.6)

Pre
(n =30)

Post
(n =28)

72.2

70.7

.78

20 (66.6)

21 (75)

.48

	
  

p-value*

Race/ethnicity, n (%)
48 (82.7)
24 (80)
24 (85.7)
.76 τ
White, non-Hispanic
___________________________________________________________________________________________________________	
  
*p-‐values	
  based	
  on	
  t-‐test	
  or	
  chi-‐square	
  analysis	
  	
  
τ
	
  White,	
  non-‐Hispanic	
  vs.	
  others	
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Table 3. Process Indicators
Overall sample
(N =58)

Pre
(n =30)

Post
(n =28)

4.44

4.67

4.21

.095

10 (17.2)

2 (6.6)

8 (28.6)

.038 τ

PHQ-9 score, mean

14.1

7.5

17.75

.06

MHN referral, n (%)

31 (53.4)

15 (50)

16 (57.1)

.61

PHQ-2 score, mean
PHQ-9, n (%)

p-value*

___________________________________________________________________________________________________________	
  
*p-values based on t-test or chi-square analysis
τ
	
  fisher’s exact test	
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Table 4. Process Outcomes
Overall sample
(N =58)

Pre
(n =30)

Post
(n =28)

p-value*

1 or 2 Mood D/O dx, n (%)

10 (17.2)

5 (16.6)

5 (17.9)

.905

Antidepressant, n (%)

30 (51.7)

16 (53.3)

14 (50)

.80

Benzodiazepine, n (%)

20 (34.5)

11 (36.6)

9 (32.1)

.72

________________________________________________________________________________________________________	
  
*p-values based on t-test or chi-square analysis
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Table 5. Protocol Non-Adherence
Documentation of protocol
non-adherence
Use of PHQ-9
MHN referral
	
  

Pre

Post

GAD completed instead. Anxiety Not appropriate for
primary MH problem.
patient presentation.
Geriatric depression scale used.
Pt. refused MHN service (n = 2) Patient refused MHN
service (n =1)
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Figure 1. Percentage of Times Clinicians Properly Documented Non-adherence
	
  
	
  
16%
13.3
14%
12%
10%

8.3

7.1

8%

5.0

6%
4%
2%
0%
No MHN referral

No PHQ-9

Reasons for Non-adherence
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Improving Depression Care for Elderly Home Health Patients:
Suggestions for Policy Change
Depression is a widespread mental health issue in the home healthcare (HH) population
(Bruce et al., 2015). Depressive symptoms exhibited by homebound and chronically ill older
adults often go under reported and undertreated (Sheeran et al., 2010) and are associated with
increased rates of re-hospitalization (Sheeran, Byers, & Bruce, 2010), falls (Byers et al., 2008),
and suicides (Raue et al., 2006). Additionally, healthcare costs are two times higher for patients
diagnosed with diabetes or heart disease with a co-morbid diagnosis of depression (INFOMC,
2013). In 2011 the Centers for Medicare and Medicaid (CMS) recommended the use of a quick,
two-item depression-screening tool, the Patient Health Questionnaire (PHQ) 2, on the Outcome
and Assessment Information Set (OASIS) C to promote recognition of depression in the HH
population. “How often the HH agency checked patients for depression” is now a quality
measure tracked by CMS. This CMS policy change has prompted HH agencies to recommend
that clinicians screen for depressive symptoms and screening is facilitated by inclusion of the
PHQ-2 in the OASIS-C assessment. However, CMS and the HH model offer little else to
encourage and support depression care. Therefore, additional polices at both the national and
local levels are needed to improve the provision of depression care in this population. This
manuscript will describe depression in the HH population and explore current evidence-based
programming options for HH agencies. Finally, recommended national and local level policy
changes will be identified.
The Problem of Depression
Older adults in need of HH services are typically homebound and require care and
monitoring of chronic health conditions such as cardiovascular diseases, diabetes, and chronic
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pulmonary disorders (Qui et al., 2010). Beck et al. (2009) reported that over 40% of homebound
elders in their program were diagnosed with at least two comorbid medical and mental illnesses.
Twelve to 25% of elders receiving HH meet the criteria for clinical depression, and these
estimates are considered conservative because mental illness is frequently not recognized (Bruce
et al., 2002; Bruce et al., 2015). In one study only 22% of elders who met criteria for depression
were being treated with antidepressants, and none were involved with psychotherapy (Bruce et
al., 2002). Raue et al. (2011) found that 32% of patients who met criteria for major or minor
depression were being treated with an antidepressant; however, none were receiving
psychotherapy, despite the finding that 18% reported wanting to be involved with this type of
treatment. These data highlight significant gaps in mental health care treatment for elderly HH
patients, particularly regarding depression, even though the consequences of untreated
depression have been well described.
Depression complicates the treatment of chronic illness from multiple angles (Katon,
2011). The mood disorder can impede chronic care management and worsen the symptom
burden of illnesses common in older age (Katon, 2011). Negative thinking and feelings of
apathy and hopelessness characteristic of depressive illnesses can lead to poor adherence to strict
medical regimens needed to keep chronic illnesses like diabetes (Acee, 2014) and heart failure
(Thomas et al., 2008) under control. Even the practitioner-patient relationship can be negatively
impacted due to the practitioner perceiving the treatment course as more complicated and
involved when a patient is depressed (Katon, 2011). Also, hormonal and immune responses
typical of depressive states can exacerbate chronic illness and limit treatment efficacy (Katon,
2011; Thomas et al., 2008).
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This may partly explain why depression increases elderly HH patients’ risk for short-term
re-hospitalization (Sheeran, Byers, & Bruce, 2010). CMS is focusing on reducing rates of
hospitalization as part of ongoing efforts to reduce costs in an out-of-control healthcare spending
climate; therefore, it is worthwhile to better understand complex factors that contribute to these
rates. In one study, depressed patients were hospitalized sooner after admission to HH than nondepressed patients (Sheeran, Byers, & Bruce, 2010). Also, the depressed patients had a
significantly higher risk of re-hospitalization within the first 2-3 weeks of receiving HH
(Sheeran, Byers, & Bruce, 2010). In another study of a sample population with a mean age of
61, depressive symptoms were associated with increased rates of re-hospitalization following an
acute myocardial infarction (MI; Reese et al., 2011). Of additional importance, 33% of elderly
adults fall each year and are hospitalized for fall-related injuries five times more often than for
any other adverse event (Centers for Disease Control [CDC], 2014]. In a 2008 (Byers et al.)
study it was found that HH patients who fell were twice as likely to be depressed. Clearly,
screening and interventions for depression should be a priority in HH efforts to prevent adverse
events and treat chronic illnesses.
Depression Care in Home Health Policy
Since July of 1999 Medicare has required clinicians who admit Medicare recipients to
HH to complete the OASIS–a lengthy and comprehensive assessment that calculates each
patient’s Home Health Resource Group (HHRG) score and case-mix adjustment index. Home
healthcare agencies are paid for each 60-day episode of care using a prospective payment system
(PPS) that adjusts payment to reflect each patient’s HHRG and case-mix.
Until January 2010, OASIS item M0590, which consisted of a checklist of some of the
symptoms of major depression, was used to screen for depression. While this item required the
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HH clinician to address depression in some form, it lacked standardization, assessment of
anhedonia, and symptom degree as well as persistence, failing to capture the full patient
presentation. Perhaps most importantly, the item was placed on the OASIS without direction
about how to ask the questions or what to do with the answers (Sheeran, Reilly, Weinberger,
Bruce, & Pomerantz, 2010).
In 2010 the OASIS-C was introduced and item M0590 was replaced by M1730, which
addressed some of these deficits. Item M1730 asks whether a standardized tool was used to
screen the patient for depression, allowing each agency to choose which tool they use. This item
outlines instruction for administration of the PHQ-2 if no other instruments are used, providing
access to a quick, standardized depression-screening tool. The PHQ-2 measures both key
symptoms of depression (depressed mood and anhedonia) as well as symptom pervasiveness and
persistence (Sheeran, Reilly, Weinberger, Bruce, & Pomerantz, 2010). This tool even gives the
clinician some guidance on how to ask the questions and score the answers, and it encourages the
clinician to consider whether additional evaluation is necessary. Noticeably, improvements have
been made to the way in which the OASIS prompts clinicians to screen for depression. However,
individual HH agencies vary widely in their use of this tool in the home setting.
Ongoing Effort to Integrate Depression Care in Home Health
According to The United States Preventative Services Task Force it is recommended that
clinicians conduct “screening for depression in adults aged 18 and older when staff-assisted
depression care supports are in place to assure accurate diagnosis, effective treatment, and
follow-up” (2002). In other words, unless an agency has a clear action plan for treatment in the
event of a position depression screen, the USPSTF recommends against screening. CMS does
not mandate that HH agencies screen for depression; however, the rate at which the HH agency
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checked for depression is a quality measure CMS monitors and publicizes. Also, the OASIS-C
asks that clinicians consider if depression intervention(s) such as medication, referral for other
treatment, or a monitoring plan for current treatment will be used. Again, however, care
management of depression is not required. These prompts and reportable quality measures
appear to be the extent of the oversight CMS provides to HH agencies for depression care.
Unfortunately, several broad-based Medicare policies do not make provision of
depression care appealing to HH agencies and, as a result, depression care is rarely integrated
into HH. Cabin (2010) addressed this issue writing, “To date, the OASIS has not placed any
burden on Medicare HH agencies to assess, screen, or intervene for depression, nor is there any
reward in the per-episode payment or quality measurement system” (Cabin, 2010, p. 172).
The presence (or absence) of a diagnosis of depression in a HH patient has no effect on
the HHRG score and, therein, has no impact on the amount of money paid to the HH agency to
care for the patient. In other words, there are no explicit financial incentives for providing quality
depression care. In fact, some HH agencies consider the provision of depression care a financial
nightmare. The PPS system financially incentivizes seeing as many patients as possible in as
little time as possible. This reward system is heavily misaligned with provided quality and
thorough chronic care management, especially potentially time-intensive depression care (Bao,
Eggman, Richardson, & Bruce, 2014). As a result, most HH agencies do not see the value in or
financial feasibility of integrating depression care programming in operations. Even though
leaders may understand the importance of identifying and addressing depression, some say it is
difficult to see financial benefit. (Bao et al., 2014).
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Evidence-Based Depression Care for Home Health
The U.S. Department of Health and Human Service Substance Abuse and Mental Health
Services Administration (SAMHSA, 2011) recognizes that many older adults do not have access
to evidence-based depression support when needed. To address this need the agency stated,
“EBPs must be available in the settings where older adults receive their care” (SAMHSA, 2011,
p. 10). What better place to intervene than in the homes of older homebound adults?
Researchers have recognized the need for HH-friendly, evidence-based depression care
management programs and a few have been developed (Bruce et al., 2015; Ell et al., 2007;
Madden-Baer, McConnell, Rosati, Rosenfeld, & Edison, 2013). For example, the Psychogeriatric
Assessment and Treatment in City Housing (PATCH) is an in-home program that stresses
depression education for important people in seniors’ lives as well as care coordination (Robbins,
Rye, German, Tlasek-Wolfson, Penrod, Rabins, & Black, 2000). The Program to Encourage
Active Rewarding Lives for Seniors (PEARLS) uses goal setting and problem solving in the
home to reduce depressive symptoms and improve patients’ quality of life (SAMSHA, 2011).
Other in-home depression care programs for seniors emphasize staff education and encourage
case communication among providers to report depressive symptoms and response to treatment,
monitoring of medications, goal setting, and connection to community-based services (Pickett,
Raue, & Bruce, 2012). A few have been developed with stakeholder interests and HH agency
realities in mind (Bruce et al., 2015; Gellis, Kenaley, & Have, 2014).
Depression care can be successfully adopted and integrated into routine HH agency
operations and can result in clinically significant outcomes in moderately to severely depressed
patients (Bruce et al., 2015). Six HH agencies from across the nation participated in a
randomized trial to test the clinical effectiveness of Depression CAREPATH, a program for
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integrating depression care into routine nursing practice. Depression CAREPATH is unique in
that agencies are encouraged to train all nurses to assess for depression and provide a variety of
interventions as appropriate or as time allows. In this way depression is viewed as a chronic
illness that the nurse would address alongside other diseases (Bruce et al., 2015).
This method of depression care is based on the Collaborative Care Model [CCM], which
is recognized globally as an effective and necessary method of integrating mental and physical
health care (Ngo et al., 2013). The CCM encourages a team-based approach to the identification
and treatment of mental illness so that roles are adapted to:
Routinely identify patients who need care; assess risk factors; educate patients about
their illness, risk factors and treatment; intervene with a combination of brief
evidence-based pharmacological and psychosocial treatments; teach self-management
skills; monitor patients’ progress and adherence to treatment; and follow-up over the long
term (Ngo et al., 2013, p. 1).
Multiple randomized-controlled trials have reported that collaborative outpatient care for
common mental health conditions, such as depression, is more clinically- and cost-effective
compared to standard treatment options (Unutzer, Harbin, & Schoenbaum, 2013). Improving
Mood, Promoting Access to Collaborative Care (IMPACT, 2012) is a well-described and
thoroughly researched collaborative care model implemented in primary care clinics where older
adults receive care. This model uses collaboration, depression care managers, psychiatrists,
outcome measurement, and an evidence-based treatment algorithm to treat depression in older
adults (IMPACT, 2012). In 2012, IMPACT had twice the effectiveness of treating depression
than treatment as usual. These positive effects lasted for at least one year after treatment ceased.
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For this reason, researchers are recommending that this model be implemented in the newly
developed Medicaid Health Homes (Unutzer, Harbin, & Schoenbaum, 2013).
Clearly, researchers have created, tested, and made solutions available. The next steps
are engaging stakeholders and implementing these programs for the benefit of our older
American citizens.
Stakeholder Interests
When a need for integrated depression care for older adults has been identified, largescale government agencies have called for solutions (SAMHSA, 2011). Delegates from the 2005
White House Conference on Aging reported the need to “improve recognition, assessment, and
treatment of mental illness and depression among older adults” as one of the top 10 resolutions.
The 2015 Conference will continue to explore healthy aging. In addition, CMS has expressed a
commitment to address the issue, although on a broader scale. The center has recently submitted
a proposed rule that would change the HH agency conditions of participation to encourage a
“more continuous integrated care process across all aspects of home health services, based on a
patient-centered assessment, care planning, service delivery, and quality assessment and
performance improvement” (Medicare and Medicaid Program: Conditions of Participation for
Home Health Agencies, 2014, p. 61166). The proposed changes emphasize the importance of
assessing patients’ psychosocial status and improving clinicians’ ability to understand how social
and emotional factors contribute to health outcomes (Medicare and Medicaid Program:
Conditions of Participation for Home Health, 2014).
The successful passage of these resolutions by congressional committees depends on the
ability of CMS and HH agencies to identify and implement cost-effective and clinically
efficacious ways to integrate care of common physical and mental health problems. CMS needs
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to encourage this practice without creating exorbitant costs to the already financially strapped
Medicare fund. In addition, HH agencies should implement these changes without breaking the
budgets of HH agencies or expanding the workloads of already-overwhelmed HH clinicians.
Both groups should ideally identify and implement solutions that have been shown to effectively
adapt to HH operations and be useful rather than burdensome for HH clinicians.
Generalist nurses have asked for training that enhances their ability to accurately assess
depression and provide effective management of this mental health problem (Liebel & Powers,
2013). HH nurses, due to their holistic training and approach to care, would like to be able to
intervene when their patients are depressed (Bao, Eggman, Richardson, & Bruce, 2014).
Depression is not a normal part of aging. Older adults deserve to have the option for care
and treatment of this disabling mental condition. In one study only 10% of patients who met
criteria for depression preferred to do nothing about their mental distress–the majority reported
wanting to feel better (Raue, Weinberger, Sirey, Meyers, & Bruce, 2011). While stigma and
negative attitudes toward mental health treatment persist among older adults, HH clinicians
should be prepared to identify and discuss depressive symptoms with their patients.
Policy Changes
Given the breadth of the problem of depression in the HH population and the
consequences of leaving it unaddressed, CMS and HH agency policy changes are needed. Policy
options range from doing nothing to fully restructuring the reimbursement policies for HH
agencies provision of care to depressed patients. However, it is crucial to identify and implement
policies that optimize integration of physical and mental health care, yet simultaneously maintain
reasonable clinician workloads. Common sense, low-risk actions can be taken at both a federal
and local level.
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Policy Recommendations
Recommendation 1: Provide additional access to evidence-based depression care
programming through the CMS website. Currently CMS provides an OASIS-C1/ICD-9
Guidance Manual available for download on their website. This manual was recently posted to
the CMS website (2014) and includes resources for various aspects of HH agency operations,
including depression care and administration of the PHQ-2; however, the information pertaining
to depression care is limited and out of date. The last update to the information was made in
2012 using research and resources that were developed before 2011, before significant changes
were made to the OASIS that impacted how HH clinicians screen for and are prompted to care
for depressed patients. HH agencies might consider implementing depression care programming
if they were more aware of various options for depression care programming that could be
adapted to their unique set of resources and operations. This resource list should be expanded to
include various options for home-based depression care that can be found in the literature and
through the Agency for Healthcare Research and Quality (AHRQ).
In addition it would be helpful for CMS to create a web-based open forum for HH
agencies to discuss barriers as well as successful implementation of evidence-based depression
care programming. Encouraging leaders to discuss goals, failed attempts, as well as successes
could promote realistic implementation of depression care.
Recommendation 2: CMS can link implementation of evidence-based depression
care to conditions of participation. As previously discussed, CMS is proposing significant
changes to HH agencies’ conditions of participation. It is recommended that HH agencies
improve the way they assess and address patients’ psychosocial status, which could increase the
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likelihood that HH agencies will make important changes to regulations and policies. Moreover,
an evidence-based approach to implementation could improve these odds.
Recommendation 3: Local HH agency policies should reflect the importance of
depression care as part of chronic illness management. On a local level, HH agencies can
acknowledge the importance of identifying and addressing depressive symptoms by making
depression care management a priority. HH leaders should be seeking out innovative ways to
adapt and implement depression care in their own agencies. Although not every program is well
suited for every HH agency, clinicians can be trained and protocols adapted to improve agencies’
ability to intervene. At the very least agencies need to have a suicide assessment and intervention
protocol for their clinicians’ awareness and their patients’ protection.
Home healthcare agencies have successfully designed and implemented chronic care
management programs for diabetes, CHF, and COPD, and similar programs can be developed for
depression. Organizations can train nurses to effectively screen for depression, monitor
antidepressant medications, and collaborate with prescribers (Bruce et al., 2015). Goal setting
and problem solving are useful skills for nurses to use with all patients, regardless of a diagnosis
of depression. While the OASIS only prompts for depression screening at admission, HH
agencies can choose to reassess symptoms of depression to measure patient progress and
intervention effectiveness. Guidelines are available for assessment and reassessment using the
PHQ-2 and PHQ-9 (Bruce et al., 2011a; Bruce et al., 2011b).
Impact
Untreated and undertreated depression in the HH population contributes to numerous
poor health outcomes (Sheeran, et al., 2010, Byers et al., 2008, Raue et al., 2006). Traditionally,
CMS and HH agency policies have not been adequately aligned with the provision of evidence-
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based depression care. Depression care in home health will not improve without making
important policy changes.
On the other hand, implementing policies that encourage HH agencies to make
depression care a priority can alleviate patients’ symptoms, especially patients with more
moderate to severe, debilitating depression (Bruce et al., 2015). Adapting the collaborative care
model for depression and chronic illness has improved patients’ engagement in treatment, their
overall physical functioning, and their quality of life (Hunkeler et al., 2006). These
improvements are key in assisting chronically ill older adults to better manage their illnesses to
prevent costly re-hospitalizations and lethal exacerbations.
The National Council on Aging (2014) reports that our current method of providing care
for chronically ill people accounts for approximately 75% of our nation’s spending on health
care, while only one percent of funds are budgeted to improve patients’ ability to manage their
illnesses. Depressed patients are 1.75 times more likely to be non-adherent to prescribed
treatment regimens compared to their non-depressed peers (Grenard et al., 2011), and can care
can cost twice that of non-depressed patients (INFOMC, 2013). Chronic illnesses are expensive,
especially if we do not support efforts to tackle key problems, such as depression.
As the US healthcare system undergoes significant transformations, the importance of
addressing mental illness will garner significant attention. HH agencies that have considered
options for incorporating depression care and have started to do so will be at a significant
advantage. Hospital systems and outpatient care providers are beginning to see the importance
of targeting mental health efforts to improve chronic illness management. Agencies that adopt
smart, innovative options for doing so will remain competitive and be able to provide true
holistic care to chronically ill older adults.

65	
  
	
  

References
Acee, A. (2014). Diabetes, Depression, and OASIS-C. Home Healthcare Nurse, 32(6),
362-369.
Bao, Y., Eggman, A., Richardson, J., & Bruce, M. (2014). Misalignment between
medicare policies and depression care in home health care: Home health provider
perspectives. Psychiatric Services, 65(7), 905-910.
Beck, R., Arizmendi, A., Purnell, C., Fultz, B., & Callahan, C. (2009). House calls for
Seniors: Building and sustaining a model of care for homebound seniors. The
American Geriatrics Socieity, 57, 1103-1109.
Bruce, M., Raue, P., Reilly, C., Greenberg, R., Meyers, B., Banerjee, S….Leon, A.,
(2015). Clinical effectiveness of integrating depression care management into
Medicare home health. The Journal of the American Medical Association,
doi:10.1001/jamainternmed.2014.5835.
Bruce, M., Raue, P., Sheeran, T., Reilly, C., Pomerantz, J., Meyers, B., . . . Zukowski, D.
(2011a). Depression care for patients at home: Depression CAREPATH: Home
care depression care management protocol, part 2. Home Healthcare Nurse,
29(8), 480-489.
Bruce, M., Sheeran, T., Raue, P., Reilly, C., Greenberg, R., Pomerantz, J., . . . Johnston,
C. (2011b). Depression care for patients at home: Depression CAREPATH:
Intervention development and implementation, part 1. Home Healthcare Nurse,
29(7), 417-426.
Byers, A., Sheeran, T., Mlodzianowski, A., Meyers, B., Nassisi, P., & Bruce, M. (2008).

66	
  
	
  

Depression and risk for adverse falls in older home health care patients. Research in
Gerontological Nursing, 1(4), 245-251.
Cabin, W. (2010). Lifting the veil from depression: OASIS-C and evidence-based
practice. Home Health Care Management & Practice, 22(3), 171-177.
doi:10.1177/1084822309348693
Centers for Disease Control [CDC]. (2014). Cost of falls among older adults. Retrieved
December 4, 2014 from
http://www.cdc.gov/HomeandRecreationalSafety/Falls/fallcost.html.
Ell, K., Unutzer, J., Aranda, M., Gibbs, N., Lee, P., & Xie, B. (2007). Managing
depression in home health care: A randomized clinical trial. Home Health Care
Services Quarterly, 26(3), 81-103.
Grenard, J., Munjas, B., Adams, J., Suttorp. M., Maglion, M…..Gellad, W. (2011).
Depression and medication adherence in the treatment of chronic disease in the
United States: A meta-analysis. Journal of General Internal Medicine, 26(10),
1175-1182.
Hunkeler, E., Katon, W., Tang, L., Williams, J., Kroenke, K., Lin, E….Unutzer, J.
(2006). Long term outcomes from the IMPACT randomized trial for depressed elderly
care patients in primary care. BJM. doi:10.1136/bmj.38683.710255.BE.
Improving Mood, Promoting Access to Collaborative Care [IMPACT]. (2012). Aims
Center. IMPACT Evidence-based depression care. Retrieved from
http://impact-uw.org/.
INFOMC. (2013). Retrieved fromhttp://www.healthintegrated.com/Portals/0/ELS%20
Presentations/Susan_Norris_March%202013.pdf

67	
  
	
  

Katon, W. (2011). Epidemiology and treatment of depression in patients with chronic
medical illness. Dialogues in Clinical Neuroscience, 13(1), 7-23.
Liebel, D. & Powers, B. (2013). Home health care nurse perceptions of geriatric
depression and disability care management. The Gerontologist.
doi: 10.1093/geront/gnt125.
Madden-Baer, R., McConnell, E., Rosati, R., Ronsenfeld, P., & Edison, I. (2013).
Implementation and evaluation of a depression care model for homebound elderly.
Journal of Nursing Care Quality, 28(1), 33-42.
Medicare and Medicaid Program: Conditions of Participation for Home Health Agencies,
42 CFR Parts 409, 410, 418, 440, 484, 485 & 488 (2014).
National Council on Aging (2014). Chronic Disease Self-Management. Retrived from
http://www.ncoa.org/assets/files/pdf/NCOA-Chronic-Desease.pdf.
Ngo, V., Rubinstein, A., Ganju, V., Kanellis, P., Loza, N., Rabaden-Diehl, C., & Daar, A.
(2013). Grand challenges: Integrating mental health care into the noncommunicable disease agenda. PLoS Med 10(5): e1001443.
doi:10.1371/journal.pmed.1001443
OASIS-C Guidance Manual. (2012). Chapter 5: Resources/Links. Retrieved from
http://www.cms.gov/Medicare/Quality-Initiatives-Patient-AssessmentInstruments/HomeHealthQualityInits/HHQIOASISUserManual.html.
Qiu, W., Dean, M., Liu, T., George, L., Gann, M., Cohen, J., & Bruce, M. (2010).
Physical and mental health of homebound older adults: An overlooked population. The
American Geriatrics Society, 58, 2423-2428.
Raue, P., Meyers, B., Rowe, J., Heo, M., & Bruce, M. (2006). Suicidal ideation among

68	
  
	
  

elderly homecare patients. International Journal of Geriatric Psychiatry, 22, 32- 37.
Raue, P., Weinberger, M., Sirey, J., Meyers, B., & Bruce, M. (2011). Preferences for
depression treatment among elderly home health care patients. Psychiatric
Services, 62(5), 532-537.
Reese, R., Freedland, K., Steinmeyer, B., Rich, M., Rackley, J., & Carney, R. (2011).
Depression and rehospitalization following acute myocardial infarction.
Circulation: Cardiovascular Quality and Outcomes, 4(6), 626-633.
Robbins, B., Rye, R., German, P. S., Tlasek-Wolfson, M., Penrod, J., Rabis, P.V., Black,
B.S. (2000). The psychogeriatric assessment and treatment in city housing
(PATCH) program for elders with metnal illness in public housing: getting
through the crack in the door. Archives of Psychiatric Nursing, 14(4), 163-172.
Sheeran, T., Byers, A., & Bruce, M. (2010). Depression and increased short-term
hospitalization risk among geriatric patients receiving home health care services.
Psychiatric Services, 61(1), 78-80.
Sheeran, T., Reilly, C., Weinberger, M., Bruce, M., & Pomerantz, J. (2010). The PHQ-2
on OASIS-C: A new resource for identifying geriatric depression among home health
patients. Home Health Care Nurse, 28(2), 92-102.
Thomas, S., Chapa, D., Friedmann, E., Durden, C., Ross, A., Lee, M., & Lee, H. (2008)
Depression in patients with heart failure: Prevalence, pathophysiological,
mechanisms, and treatment. Critical Care Nurse, 28(2), 40-55.
Unutzer, J., Harbin, H., & Schoenbaum, M. (2013). The collaborative care model: an approach
for integrating physical and mental health care in Medicaid health homes. Retrieved from

69	
  
	
  

http://www.medicaid.gov/State-Resource-Center/Medicaid-State-TechnicalAssistance/Health-Homes-Technical-Assistance/Downloads/HH-IRC-Collaborative-513.pdf.

70	
  
	
  

	
  
	
  
	
  
	
  
Capstone Report Conclusion
Sarah Royse Schirmer, M. Ed., BSN, LPCC, RN
University of Kentucky

	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

71	
  
	
  

Conclusion
As described in the first manuscript depression is associated with multiple negative health
outcomes and should be a part of chronic disease management programs implemented in home
healthcare (HH). Unfortunately, patient, clinician, agency, and policy barriers impede effective
depression care delivery in the HH population. Even so, research has shown that depression care
programming can improve nurses’ ability to effectively screen for depressed patients (Brown et
al., 2010; Bruce et al., 2007) and reduce depression scores, especially in patients with moderate
to severe levels of depression (Bruce et al., 2015).
While HH clinicians in this report were trained to screen patients for depression and refer
patients who scored high during admission, results of the process evaluation indicated that
additional steps must be taken by the HH agency so that future evaluation efforts more
accurately reflect clinician practice. Interpreted cautiously, the process evaluation indicated that
while training did improve clinician use of the PHQ-9, practice did not drastically change after
protocol implementation. Not all patients who met criteria for further evaluation and treatment
based on initial screening using the PHQ-2 received depression care. The researcher suggested
this could be due to protocol reliance on inadequate numbers of specialized mental health
clinicians. Additionally, it is suspected that Medicare policies that are not clearly supportive of
depression care contribute to this finding. However, there are several ways in which the DNP can
initiate practice change to increase access to depression care and improve depression outcomes
for elderly HH patients.
The final manuscript investigated ways in which local and national level policies can be
changed to encourage the use of evidence-based, in-home depression care programming. Like all
areas of healthcare, home health resources are limited and budgets must be carefully considered.
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Depression care models that understand the realities of HH have been developed and suggest that
all nurses should be trained to screen and provide interventions within their scope of practice
(Bruce et al., 2015). This increases the number of adequately trained professionals available to
manage the mental health condition and improves the likelihood that all depressed patients will
have access to depression care. Medicare policies should reward agencies and clinicians who
chose to improve chronic care management by using evidence-based depression care.
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Appendix A
The Patient Health Questionnaire-2 (PHQ-2)
Over the past 2 weeks, how often have you been
bothered by any of the following problems?

Not
At All

More
Several Than Half
Days
the Days

Nearly
Every
Day

1. Little interest or pleasure in doing things

0

1

2

3

2. Feeling down, depressed or hopeless

0

1

2

3

(Kroenke, Spitzer, & Williams, 2003)
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Appendix B

Appendix B
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Appendix C
Tips for Administering the PHQ-2
1. Aim to ask the questions in a straightforward and empathetic manner. For example you may
want to say, “Now I’m going to ask you some questions about how you’ve been feeling.”
The more comfortable you are asking the questions, the more comfortable your patient will
be answering these questions honestly and thoroughly.
2. It is important to screen for depression even if the patient is already taking an antidepressant
medication at admission. There are several reasons why a patient who is taking an
antidepressant may still be depressed and need additional intervention.
3. Consider the following suggestions for asking the PHQ-2 questions:
a. Split the question into “bite sized” pieces. For example, “Have you had little interest or
pleasure in doing things?” If yes...”How long have you been feeling this way?” or
“Have you been feeling this way for at least two weeks?” How often have you been
feeling this way? Several days, more than half the days, or nearly every day?”
b. You may want to use the large print response card so that your patients can read the
options and chose what best fits their experience. This can reduce confusion and
work better for visually and hearing impaired patients.
4. If a patient has severe cognitive impairment, the PHQ-2 may not be a reliable screening
tool. You can try to answer the questions using caregiver response; however, this is also
not the most reliable way to use this screening instrument. If you think that the PHQ-2 is
not a reliable screener for your patient and you suspect your patient may have depressive
symptoms consider a MHN evaluation to further screen for depression.
5. Cutoff scores for the PHQ-2 are as follows:
a. < 3: correctly identifies 78% of patients who are not
depressed b. > 3: correctly identifies 87% of patients who are
depressed
7. If your patient scores > 3 on the PHQ2, talk to them and/or the caregiver about the MHN
service. Here are some ways you might initiate that conversation with your patient
and/or their caregiver:
a. “Based on your responses to this screening tool, it seems like you may be struggling with
some feelings of depression. Would you agree to talk to one of our nurses who
specializes in helping people cope with those feelings?”
b. “I’m concerned that you may need more intensive help with your feelings of depression.
I’d like to ask for one of our mental health nurses to see you. Would that be ok with you?”
c. If there is already a prescription, “Your MD/NP would like for one of our MHNs to see you
about your feelings of depression. They will be by within the week to visit with you and

76	
  
	
  

References
Acee, A. (2014). Diabetes, depression, and OASIS-C. Home Healthcare Nurse, 32(6), 362-369.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders
(5th ed.). Arlington, VA: American Psychiatric Publishing.
Bao, Y., Eggman, A., Richardson, J., & Bruce, M. (2014). Misalignment between medicare
policies and depression care in home health care: Home health provider perspectives.
Psychiatric Services, 65(7), 905-910.
Beck, R., Arizmendi, A., Purnell, C., Fultz, B., & Callahan, C. (2009). House calls for
Seniors: Building and sustaining a model of care for homebound seniors. The
American Geriatrics Socieity, 57, 1103-1109.
Brown, E., Kaiser, R., & Gellis, Z. (2007). Screening and assessment of late-life depression in
home healthcare: Issues and challenges. Annals of Long-Term Care, 15(10), 2-7.
Brown, E., Raue, P., Roos, B., Sheeran, T., & Bruce, M. (2010). Training nursing staff to
recognize depression in home healthcare. Journal of the American Geriatrics Society, 58,
122-128. doi: 10.1111/j1532-5415.2009.02626.x.
Bruce, M., Brown, E., Raue, P., Mlodzianowski, A., Meyers, B., Leon, A., . . . Nassisi, P. (2007).
A randomized trial of depression assessment intervention in home health care. Journal of
the American Geriatrics Society, 55, 1793-1800. doi: 10.1111/j.1532-5415.2007.01419.x.
Bruce, M., McAvay, G., Raue, P., Brown, E., Meyers, B., Keohane, D., . . . Weber, C. (2002).
Major depression in elderly home health care patients. American Journal of Psychiatry,
159(8), 1367-1374.
Bruce, M., Raue, P., Reilly, C., Greenberg, R., Meyers, B., Banerjee, S….Leon, A.,
(2014). Clinical effectiveness of integrating depression care management into

77	
  
	
  

Medicare home health. The Journal of the American Medical Association,
doi:10.1001/jamainternmed.2014.5835.
Bruce, M., Raue, P., Sheeran, T., Reilly, C., Pomerantz, J., Meyers, B., . . . Zukowski, D.
(2011a). Depression care for patients at home: Depression CAREPATH: Home care
depression care management protocol, part 2. Home Healthcare Nurse, 29(8), 480-489.
Bruce, M., Sheeran, T., Raue, P., Reilly, C., Greenberg, R., Pomerantz, J., . . . Johnston, C.
(2011b). Depression care for patients at home: Depression CAREPATH: Intervention
development and implementation, part 1. Home Healthcare Nurse, 29(7), 417-426.
Byers, A., Sheeran, T., Mlodzianowski, A., Meyers, B., Nassisi, P., & Bruce, M. (2008).
Depression and risk for adverse falls in older home health care patients. Research in
Gerontological Nursing, 1(4), 245-251.
Cabin, W. (2010). Lifting the veil from depression: OASIS-C and evidence-based practice.
Home Health Care Management & Practice, 22(3), 171-177.
doi:10.1177/1084822309348693
Caffrey, C., Sengupta, M., Moss, A., Harris-Kojetin, L., & Valverde, R. (2011). Home health
care and discharged hospice care patients: United States, 2000 and 2007. National Health
Statistics Reports, 38, 1-28.
Centers for Disease Control and Prevention. (2012). Depression is not a normal part of
growing older. Healthy Aging. Retrieved from
http://www.cdc.gov/aging/mentalhealth/depression.htm.
Centers for Disease Control [CDC]. (2014). Cost of falls among older adults. Retrieved
December 4, 2014 from
http://www.cdc.gov/HomeandRecreationalSafety/Falls/fallcost.html.

78	
  
	
  

Chism, L. A. (2010). The Doctor of Nursing Practice: A Guidebook for Role Development and
Professional Issues. Sudbury, MA: Jones and Bartlett.
Chunyu, L., Friedman, B., Conwell, Y., & Fiscella, K. (2007). Validity of the Patient Health
Questionnaire 2 (PHQ-2) in identifying major depression in older people. Journal of
American Geriatrics Society, 55(4), 596-602.
Diefenbach, G., Tolin, D., & Gilliam, C. (2011). Impairments in life quality among clients in
geriatric home care: Associations with depressive and anxiety symptoms. Geriatric
Psychiatry, 27, 828-835.
Egede, L. E. (2007). Major depression in individuals with chronic medical disorders:
prevalence, correlates, and association with health resource utilization, lost productivity,
and functional disability. General Hospital Psychiatry, 29(5), 409- 416.
Ell, K., Unutzer, J., Aranda, M., Gibbs, N., Lee, P., & Xie, B. (2007). Managing depression in
home health care: A randomized clinical trial. Home Health Care Services Quarterly,
26(3), 81-103.
Ell, K., Unutzer, J., Aranda, M., Sanchez, K., & Lee, P. (2005). Routine PHQ-9 depression
screening in home health care: Depression prevalence, clinical and treatment
characteristics, and screening implementation. Home Health Care Services Quarterly,
24(4), 1-19.
Fulop, G., Strain, J. J., & Stettin, G. (2003). Congestive heart failure and depression in
older adults: clinical course and health services use 6 months after hospitalization.
Psychosomatics, 44(5), 367-373.
Gellis, Z. (2010). Depression screening in medically ill homecare elderly. Best Practices in
Mental Health, 6(1), 1-16.

79	
  
	
  

Grembowski, D., (2001). The Practice of Health Program Evaluation. Thousand Oaks, CA:
Sage Publications.
Grenard, J., Munjas, B., Adams, J., Suttorp. M., Maglion, M…..Gellad, W. (2011).
Depression and medication adherence in the treatment of chronic disease in the
United States: A meta-analysis. Journal of General Internal Medicine, 26(10),
1175-1182.
Guide to Community Preventative Services. (2014). Interventions to reduce depression among
older adults: Home-based depression care management. Retrieved from
http://www.thecommunityguide.org/mentalhealth/depression-home.html.
Hodges, B. C., & Videto, D. M. (2011). Assessment and Planning in Health Programs. Sudbury,
MA: Jones & Bartlett Learning.
Hunkeler, E., Katon, W., Tang, L., Williams, J., Kroenke, K., Lin, E….Unutzer, J.
(2006). Long term outcomes from the IMPACT randomized trial for depressed elderly
care patients in primary care. BJM. doi:10.1136/bmj.38683.710255.BE.
Improving Mood, Promoting Access to Collaborative Care [IMPACT]. (2012). Aims
Center. IMPACT Evidence-based depression care. Retrieved from
http://impact-uw.org/.
INFOMC. (2013). Retrieved fromhttp://www.healthintegrated.com/Portals/0/ELS%20
Presentations/Susan_Norris_March%202013.pdf
Katon, W. J. (2011). Epidemiology and treatment of depression in patients with chronic
medical illness. Dialogues in Clinical Neuroscience, 13(1), 7-23.

80	
  
	
  

Kroenke, K., Spitzer, R., & Williams, J. (2003). The Patient Health Questionnaire-2: Validity of
a two-item depression screener. Medical Care, 41(11), 1284-1292.
Liebel, D., & Powers, B. (2013). Home health care nurse perceptions of geriatric depression and
disability care. The Gerontologist. 1-15. doi: 10.1093/geront/gnt125.
Linden, A., Adams, J. L., Roberts, N. (2004). Evaluating disease management program
effectiveness adjusting for enrollment (tenure) and seasonality. Research in
Healthcare Financial Management, 9(1), 57-68.
Madden-Baer, R., McConnell, E., Rosati, R., Ronsenfeld, P., & Edison, I. (2013). Implementaion
and evaluation of a depression care model for homebound elderly. Journal of Nursing
Care Quality, 28(1), 33-42.
Mantyselka, P., Korniloff, K., Saaristo, T., Koponen, H., Eriksson, J., Puolijoki, H., . . . Vanhala,
M. (2011). Association of depressive symptoms with impaired glucose regulation,
screen-detected, and previously known type 2 diabetes. Diabetes Care, 34(1), 71-76.
Medicare and Medicaid Program: Conditions of Participation for Home Health Agencies,
42 CFR Parts 409, 410, 418, 440, 484, 485 & 488 (2014).
National Association for Home Care & Hospice. (2010). Basic Statistics About Home Care.
Retrieved from http://www.nahc.org/assets/1/7/10HC_Stats.pdf.
National Council on Aging (2014). Chronic Disease Self-Management. Retrived from
http://www.ncoa.org/assets/files/pdf/NCOA-Chronic-Desease.pdf.
Ngo, V., Rubinstein, A., Ganju, V., Kanellis, P., Loza, N., Rabaden-Diehl, C., & Daar, A.
(2013). Grand challenges: Integrating mental health care into the noncommunicable disease agenda. PLoS Med 10(5): e1001443.
doi:10.1371/journal.pmed.1001443

81	
  
	
  

Park, M., Katon, W. J., & Wolf, F. M. (2013). Depression and risk of mortality in
individuals with diabetes: a meta-analysis and systematic review. General
Hospital Psychiatry, 35(3), 217-225.
Pickett, Y., Raue, P., & Bruce, M. (2012). Late-life depression in home healthcare. Aging
Health, 8(3), 273-284. doi: 10.2217/ahe.12.28.
Qiu, W., Dean, M., Liu, T., George, L., Gann, M., Cohen, J., & Bruce, M. (2010). Physical and
mental health of homebound older adults: An overlooked population. The American
Geriatrics Society, 58, 2423-2428.
Raue, P., Meyers, B., Rowe, J., Heo, M., & Bruce, M. (2006). Suicidal ideation among elderly
homecare patients. International Journal of Geriatric Psychiatry, 22, 32-37.
Raue, P., Weinberger, M., Sirey, J., Meyers, B., & Bruce, M. (2011). Preferences for
depression treatment among elderly home health care patients. Psychiatric
Services, 62(5), 532-537.
Reese, R. L., Freedland, K. E., Steinmeyer, B. C., Rich, M. W., Rackley, J. W., &
Carney, R. M. (2012). Depression and rehospitalization following acute
myocardial infarction. Circulation: Cardiovascular Quality and Outcomes, 4(6),
626-633.
Robbins, B., Rye, R., German, P. S., Tlasek-Wolfson, M., Penrod, J., Rabis, P.V., Black,
B.S. (2000). The psychogeriatric assessment and treatment in city housing
(PATCH) program for elders with metnal illness in public housing: getting
through the crack in the door. Archives of Psychiatric Nursing, 14(4), 163-172.

82	
  
	
  

Shao, H., Peng, T., Bruce, M., & Bao, Y. (2011). Diagnosed depression among medicare home
health patients: National prevalence estimates and key characteristics. Psychiatric
Services, 62(5), 538-540.
Sheeran, T., Byers, A., & Bruce, M. (2010). Depression and increased short-term hospitalization
risk among geriatric patients receiving home health care services.
Sheeran, T., Reilly, C., Weinberger, M., Bruce, M., & Pomerantz, J. (2010). The PHQ-2 on
OASIS-C: A new resource for identifying geriatric depression among home health
patients. Home Health Care Nurse, 28(2), 92-102.
Thobaben, M. (2013). Psychiatric home health care skilled nursing services. Home Health Care
Management & Practice, 25(1), 32-34.
Thomas, S., Chapa, D., Friedmann, E., Durden, C., Ross, A., Lee, M., & Lee, H. (2008).
Depression in patients with heart failure: Prevalence, pathophysiological mechanisms,
and treatment. Critical Care Nurse, 28(2), 40-55.
Unutzer, J., Harbin, H., & Schoenbaum, M. (2013). The collaborative care model: an approach
for integrating physical and mental health care in Medicaid health homes. Retrieved from
http://www.medicaid.gov/State-Resource-Center/Medicaid-State-TechnicalAssistance/Health-Homes-Technical-Assistance/Downloads/HH-IRC-Collaborative-513.pdf.
U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services.
(2014). Home health services. In Your Medicare Services. Retrieved from
http://www.medicare.gov/coverage/home-health-services.html.
Valente, S. (2005). Detecting and evaluating depression among elderly patients in home health.
Home Health Care Management & Practice, 17(2), 101-108.

83	
  
	
  

